Tryptophan (Trp) is not only a nutrient enhancer but also has systemic effects. Trp metabolites signaling through the well-known aryl hydrocarbon receptor (AhR) constitute the interface of microbiome-gut-brain axis.
However, the pathway through which Trp metabolites affect central nervous system (CNS) function have not been fully elucidated. AhR participates in a broad variety of physiological and pathological processes that also highly relevant to intestinal homeostasis and CNS diseases.
4-Arm PEG-GA |
|
abx085098-200l |
Abbexa |
200 µl |
EUR 712.5 |
4-Arm PEG-GA |
|
abx085098-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 760.8 |
|
|
4-Arm PEG-GA |
|
abx085098-2kDa1g |
Abbexa |
2 kDa; 1 g |
EUR 427.2 |
|
|
8-Arm PEG-GA |
|
abx085109-100l |
Abbexa |
100 µl |
EUR 250 |
8-Arm PEG-GA |
|
abx085109-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 393.6 |
|
|
8-Arm PEG-GA |
|
abx085109-10kDa5g |
Abbexa |
10 kDa; 5 g |
EUR 744 |
|
|
8-Arm PEG-GA |
|
abx085109-1ml |
Abbexa |
1 ml |
EUR 275 |
8-Arm PEG-GA |
|
abx085109-200l |
Abbexa |
200 µl |
EUR 250 |
8-Arm PEG-GA |
|
abx085109-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 744 |
|
|
8-Arm PEG-GA |
|
abx085109-40kDa1g |
Abbexa |
40 kDa; 1 g |
EUR 427.2 |
|
|
PEG-G-CSF |
|
RP250004 |
Biochempeg |
Inquire |
Ask for price |
4-Arm PEG-GAS |
|
abx085093-100l |
Abbexa |
100 µl |
EUR 312.5 |
4-Arm PEG-GAS |
|
abx085093-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 526.8 |
|
|
4-Arm PEG-GAS |
|
abx085093-10kDa5g |
Abbexa |
10 kDa; 5 g |
EUR 878.4 |
|
|
4-Arm PEG-GAS |
|
abx085093-1ml |
Abbexa |
1 ml |
EUR 350 |
4-Arm PEG-GAS |
|
abx085093-200l |
Abbexa |
200 µl |
EUR 312.5 |
4-Arm PEG-GAS |
|
abx085093-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 878.4 |
|
|
4-Arm PEG-GAS |
|
abx085093-2kDa1g |
Abbexa |
2 kDa; 1 g |
EUR 477.6 |
|
|
4-Arm PEG-GAA |
|
abx085100-100l |
Abbexa |
100 µl |
EUR 275 |
4-Arm PEG-GAA |
|
abx085100-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 460.8 |
|
|
4-Arm PEG-GAA |
|
abx085100-10kDa5g |
Abbexa |
10 kDa; 5 g |
EUR 760.8 |
|
|
4-Arm PEG-GAA |
|
abx085100-1ml |
Abbexa |
1 ml |
EUR 300 |
4-Arm PEG-GAA |
|
abx085100-200l |
Abbexa |
200 µl |
EUR 275 |
4-Arm PEG-GAA |
|
abx085100-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 760.8 |
|
|
4-Arm PEG-GAA |
|
abx085100-2kDa1g |
Abbexa |
2 kDa; 1 g |
EUR 427.2 |
|
|
8-Arm PEG-GAA |
|
abx085111-100l |
Abbexa |
100 µl |
EUR 250 |
8-Arm PEG-GAA |
|
abx085111-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 393.6 |
|
|
8-Arm PEG-GAA |
|
abx085111-10kDa5g |
Abbexa |
10 kDa; 5 g |
EUR 744 |
|
|
8-Arm PEG-GAA |
|
abx085111-1ml |
Abbexa |
1 ml |
EUR 275 |
8-Arm PEG-GAA |
|
abx085111-200l |
Abbexa |
200 µl |
EUR 250 |
8-Arm PEG-GAA |
|
abx085111-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 744 |
|
|
8-Arm PEG-GAA |
|
abx085111-40kDa1g |
Abbexa |
40 kDa; 1 g |
EUR 427.2 |
|
|
8-Arm PEG-GAS |
|
abx085116-100l |
Abbexa |
100 µl |
EUR 275 |
8-Arm PEG-GAS |
|
abx085116-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 393.6 |
|
|
8-Arm PEG-GAS |
|
abx085116-10kDa5g |
Abbexa |
10 kDa; 5 g |
EUR 744 |
|
|
8-Arm PEG-GAS |
|
abx085116-1ml |
Abbexa |
1 ml |
Ask for price |
8-Arm PEG-GAS |
|
abx085116-200l |
Abbexa |
200 µl |
EUR 837.5 |
8-Arm PEG-GAS |
|
abx085116-20kDa5g |
Abbexa |
20 kDa; 5 g |
EUR 744 |
|
|
8-Arm PEG-GAS |
|
abx085116-40kDa1g |
Abbexa |
40 kDa; 1 g |
EUR 427.2 |
|
|
PCL(5K)-PEG-Galactose |
|
abx085406-100l |
Abbexa |
100 µl |
EUR 762.5 |
PCL(5K)-PEG-Galactose |
|
abx085406-1ml |
Abbexa |
1 ml |
Ask for price |
PCL(5K)-PEG-Galactose |
|
abx085406-200l |
Abbexa |
200 µl |
Ask for price |
PCL(5K)-PEG-Galactose |
|
abx085406-2kDa1g |
Abbexa |
2 kDa; 1 g |
EUR 684 |
|
|
PCL(5K)-PEG-Galactose, 2K |
|
HE116072-2K-G |
Biochempeg |
G |
EUR 430.8 |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
KRIBIOLISA PEG-GCSF (Pegylated Filgrastim) ELISA |
|
KBBA10 |
Krishgen |
1 x 96 wells |
EUR 676.5 |
18:1 PEG1000 PE |
|
HY-155932 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: 18:1 PEG1000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing. |
18:1 PEG3000 PE |
|
HY-155933 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: 18:1 PEG3000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing. |
18:1 PEG5000 PE |
|
HY-155934 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: 18:1 PEG5000 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing. |
18:1 PEG2000 PE |
|
HY-144010 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: 18:1 PEG2000 PE (18:1 PEG-PE) is a polyethyleneglycol/phosphatidyl-ethanolamine conjugate. 18:1 PEG2000 PE can be used for drug delivery[1]. |
18:1 PEG350 PE |
|
HY-155930 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: 18:1 PEG350 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing. |
18:1 PEG550 PE |
|
HY-155931 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: 18:1 PEG550 PE is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing. |
AzoDye-1 PEG10 Alkyne |
|
2415-1mg |
AAT Bioquest |
1 mg |
EUR 151 |
|
|
|
Description: AzoDye-1 PEG10 alkyne is an excellent building block for labeling azide-containing molecules. |
PEG3-tetrazine, 1 g |
|
1978-1g |
Lumiprobe |
1 g |
EUR 793.2 |
DBCO PEG13 NHS 1 µmol scale |
|
26-6746-01 |
Gene Link |
1 Each |
Ask for price |
AzoDye-1 PEG10 Succinimidyl Ester |
|
2403-5mg |
AAT Bioquest |
5 mg |
EUR 97 |
|
|
|
Description: AzoDye-1 PEG10 Succinimidyl Ester is an excellent building block for labeling amino-containing molecules. |
JBScreen Membrane 1 (PEG 400 to PEG 2000 MME based) |
|
M-CS-301L |
MiTeGen |
24 solutions |
EUR 414 |
|
Description: JBScreen Membrane 1 (PEG 400 to PEG 2000 MME based) |
PEG3 dicarboxylic acid, 1 g |
|
1715-1g |
Lumiprobe |
1 g |
EUR 423.6 |
DBCO PEG4 NHS 1 µmol scale |
|
26-6745-01 |
Gene Link |
1 Each |
Ask for price |
Azide PEG4 NHS 1 µmol scale |
|
26-6754-01 |
Gene Link |
1 Each |
Ask for price |
Lenti ORF clone of Peg10 (mGFP-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, encoding isoform 1 |
|
MR224445L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Alkyne PEG4 NHS 1 µmol scale |
|
26-6752-01 |
Gene Link |
1 Each |
Ask for price |
JBScreen Classic 1 (PEG 400 to 3000 based) |
|
M-CS-101L |
MiTeGen |
24 solutions |
EUR 249 |
|
Description: JBScreen Classic 1 (PEG 400 to 3000 based) |
Peg12 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|
K6370802 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15) |
|
4066201.05 |
Bachem |
0.5 mg |
EUR 240.45 |
|
|
PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15) |
|
4066201.1 |
Bachem |
1 mg |
EUR 422.42 |
|
|
PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15) |
|
H-8348.0500 |
Bachem |
0.5mg |
EUR 410.4 |
|
Description: Sum Formula: C66H101N17O29S+PEG30K |
PEG30K-Cys-AEEAc-Fibrinopeptide A (1-15) |
|
H-8348.1000 |
Bachem |
1.0mg |
EUR 691.2 |
|
Description: Sum Formula: C66H101N17O29S+PEG30K |
PEG10 sgRNA CRISPR Lentivector (Human) (Target 1) |
|
K1626702 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Peg12 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|
K3769502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Peg10 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|
K4676402 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PEG10 (untagged)-Human paternally expressed 10 (PEG10), transcript variant 1 |
|
SC108513 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (untagged)-Human paternally expressed 10 (PEG10) transcript variant 1 |
|
SC328573 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (untagged)-Human paternally expressed 10 (PEG10), transcript variant 1 |
|
SC318188 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (untagged)-Human paternally expressed 10 (PEG10), transcript variant 1 |
|
SC324334 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF clone of Peg10 (Myc-DDK-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, encoding isoform 1 |
|
MR224445L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Biotin PEG2 amine *CAS 138529-46-1* |
|
3014-5mg |
AAT Bioquest |
5 mg |
EUR 109 |
|
|
|
Description: This carbonyl-reactive biotin derivative contains a long arm (~20 angstrom) increase its avidin-binding affinity. |
Azide PEG3 Maleimide 1 µmol scale |
|
26-6761-01 |
Gene Link |
1 Each |
Ask for price |
Peg10 (untagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, (10ug) |
|
MC223182 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (GFP-tagged) - Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RG208683 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (GFP-tagged) - Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RG229935 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (GFP-tagged) - Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RG231501 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (GFP-tagged) - Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RG223371 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti ORF particles, Peg10 (GFP-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, encoding isoform 1, 200ul, >10^7 TU/mL |
|
MR224445L4V |
Origene Technologies GmbH |
200 µl |
Ask for price |
Peg10 (GFP-tagged) - Mouse paternally expressed 10 (Peg10) transcript variant 1, (10ug) |
|
MG224445 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Peg10 (GFP-tagged) - Mouse paternally expressed 10 (Peg10) transcript variant 1, (10ug) |
|
MG225144 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Peg10 (Myc-DDK-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1 |
|
MR224445 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Peg10 (Myc-DDK-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1 |
|
MR225144 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (Myc-DDK-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RC231501 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (Myc-DDK-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RC229935 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (Myc-DDK-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RC223371 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG10 (Myc-DDK-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RC208683 |
Origene Technologies GmbH |
10 µg |
Ask for price |
JBScreen PEG/Salt 1 |
|
M-CS-141 |
MiTeGen |
24 solutions |
EUR 263 |
|
Description: JBScreen PEG/Salt 1 |
pEGFP-C1-LMP-1 |
|
PPL80108-2a |
Bioworld Biotech |
1149bp |
EUR 218 |
|
|
|
Description: pEGFP-C1 |
pEGFP-C3-Bif-1 |
|
PPL00333-2a |
Bioworld Biotech |
1098bp |
EUR 218 |
|
|
|
Description: pEGFP-C3 |
Lenti ORF particles, Peg10 (Myc-DDK-tagged) - Mouse paternally expressed 10 (Peg10), transcript variant 1, encoding isoform 1, 200ul, >10^7 TU/mL |
|
MR224445L3V |
Origene Technologies GmbH |
200 µl |
Ask for price |
PEG3 (untagged)-Human paternally expressed 3 (PEG3), transcript variant 1 |
|
SC128281 |
Origene Technologies GmbH |
10 µg |
Ask for price |
PEG3 sgRNA CRISPR Lentivector (Human) (Target 1) |
|
K1626502 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Peg3 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|
K4341802 |
ABM |
1.0 ug DNA |
EUR 184.8 |
pEGFP-N1-Caspase 1 |
|
PPL00392-2e |
Bioworld Biotech |
1212bp |
EUR 218 |
|
|
|
Description: pEGFP-N1 |
Halo Chloro Tag C6 PEG4 NHS 1 µmol scale |
|
26-6455-01 |
Gene Link |
1 Each |
Ask for price |
PEG3AS sgRNA CRISPR Lentivector (Human) (Target 1) |
|
K1626602 |
ABM |
1.0 ug DNA |
EUR 184.8 |
PEG3 (GFP-tagged) - Human paternally expressed 3 (PEG3), transcript variant 1 |
|
RG215328 |
Origene Technologies GmbH |
10 µg |
Ask for price |
iFluor®488-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)* |
|
17041 |
AAT Bioquest |
25 nmoles |
EUR 101 |
|
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR. |
iFluor®488-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)* |
|
17041-25nmoles |
AAT Bioquest |
25 nmoles |
EUR 99 |
|
|
|
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR. |
iFluor®555-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)* |
|
17042 |
AAT Bioquest |
25 nmoles |
EUR 101 |
|
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR. |
iFluor®555-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)* |
|
17042-25nmoles |
AAT Bioquest |
25 nmoles |
EUR 99 |
|
|
|
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR. |
iFluor®647-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)* |
|
17043 |
AAT Bioquest |
25 nmoles |
EUR 101 |
|
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labeled DNA via conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR. |
iFluor®647-PEG12-dUTP *1 mM in Tris Buffer (pH 7.5)* |
|
17043-25nmoles |
AAT Bioquest |
25 nmoles |
EUR 99 |
|
|
|
Description: The dye-modified deoxyuridine 5'-triphosphates are one of the most common methods to produce dye-labelled DNA via the conventional enzymatic incorporation methods such as reverse transcription, nick translation, random primed labeling, or PCR. |
JBScreen PEG/Salt 1 - 4 |
|
M-CS-145 |
MiTeGen |
4 Kits |
EUR 858 |
|
Description: JBScreen PEG/Salt 1 - 4 |
pEGFP-N1-PTEN(1-185aa) |
|
PPL00065-2d |
Bioworld Biotech |
555bp |
EUR 218 |
|
|
|
Description: pEGFP-N1 |
PEG3 (Myc-DDK-tagged)-Human paternally expressed 3 (PEG3), transcript variant 1 |
|
RC215328 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Lenti-ORF clone of PEG10 (mGFP-tagged)-Human paternally expressed 10 (PEG10), transcript variant 1 |
|
RC231501L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
Via the AhR-dependent mechanism, Trp metabolites connect bidirectional signaling between the gut microbiome and the brain, mediated via immune, metabolic, and neural (vagal) signaling mechanisms, with downstream effects on behavior and CNS function. These findings shed light on the complex Trp regulation of microbiome-gut-brain axis and add another facet to our understanding that dietary Trp is expected to be a promising noninvasive approach for alleviating systemic diseases.